Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Teva
Federal Trade Commission
Cerilliant
Boehringer Ingelheim
Chubb
Harvard Business School
Fish and Richardson
Argus Health
Medtronic

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,985,305

« Back to Dashboard

Which drugs does patent 5,985,305 protect, and when does it expire?

Patent 5,985,305 protects VIADUR and is included in one NDA.

This patent has seventy-seven patent family members in twenty-nine countries.
Summary for Patent: 5,985,305
Title: Sustained delivery of an active agent using an implantable system
Abstract:The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
Inventor(s): Peery; John R. (Stanford, CA), Dionne; Keith E. (Menlo Park, CA), Eckenhoff; James B. (Los Altos, CA), Landrau; Felix A. (Punta Gorda, FL), Lautenbach; Scott D. (San Mateo, CA), Magruder; Judy A. (Mountain View, CA), Wright; Jeremy C. (Los Altos, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:08/943,007
Patent Claim Types:
see list of patent claims
Delivery; Device; Formulation;

Drugs Protected by US Patent 5,985,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Ortho Mcneil Janssen VIADUR leuprolide acetate IMPLANT;IMPLANTATION 021088-001 Mar 3, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 5,985,305

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,395,292 Sustained delivery of an active agent using an implantable system ➤ Subscribe
5,728,396 Sustained delivery of leuprolide using an implantable system ➤ Subscribe
8,080,259 Sustained delivery of an active agent using an implantable system ➤ Subscribe
6,132,420 Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems ➤ Subscribe
6,635,268 Sustained delivery of an active agent using an implantable system ➤ Subscribe
6,261,584 Sustained delivery of an active agent using an implantable system ➤ Subscribe
6,156,331 Sustained delivery of an active agent using an implantable system ➤ Subscribe
8,535,701 Sustained delivery of an active agent using an implantable system ➤ Subscribe
7,655,257 Sustained delivery of an active agent using an implantable system ➤ Subscribe
8,298,562 Sustained delivery of an active agent using an implantable system ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,985,305

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 006079 ➤ Subscribe
Argentina 010595 ➤ Subscribe
Austria 235224 ➤ Subscribe
Austria 245042 ➤ Subscribe
Austria 277595 ➤ Subscribe
Austria 281153 ➤ Subscribe
Austria 284202 ➤ Subscribe
Austria 303792 ➤ Subscribe
Australia 1701797 ➤ Subscribe
Australia 5175998 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
US Department of Justice
US Army
Cantor Fitzgerald
Boehringer Ingelheim
Fuji
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot